Validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity and tx response - Inflammatix

Skip to main content Skip to footer Opens in a new tab

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Warsinke HC, et al. JAMA. Oct 2018.

© Copyright 2026, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement | Supplier Terms and Conditions

Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of Inflammatix, Inc.